Prosecution Insights
Last updated: August 16, 2026

Examiner: HUANG, GIGI GEORGIANA

Tech Center 1600 • Art Units: 1611 1612 1613 1617 1621 1627 1629

This examiner grants 32% of resolved cases

Performance Statistics

31.7%
Allow Rate
-28.3% vs TC avg
654
Total Applications
+30.6%
Interview Lift
1432
Avg Prosecution Days
Based on 609 resolved cases, 2023–2026

Rejection Statute Breakdown

1.3%
§101 Eligibility
11.3%
§102 Novelty
38.9%
§103 Obviousness
26.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18546258 TREATMENT OF MYOPIA Non-Final OA University of Utah Research Foundation
18518772 COMPOSITION FOR IMPROVING OR PREVENTING IRON DEFICIENCY ANAEMIA Non-Final OA AJINOMOTO CO., INC.
17616701 CARBOCYCLIC NUCLEOSIDE ANALOGUE Non-Final OA Ludwig-Maximilians-Universität München
17924198 USE OF SYMPATHETIC ACTIVATION INHIBITOR AND/OR ALPHA 1-ADRENERGIC RECEPTOR INHIBITOR IN PREPARING MEDICINE FOR TREATING DRY EYES Final Rejection Eye Institute of Shandong First Medical University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month